VA Personalis Reports Preliminary Q4 Revenues up More Than 2 Percent The company is expecting continued growth in its oncology orders in Q4 2021 to translate to significant revenue growth for that business next year. Castle Biosciences Awarded VA Supply Contract for Melanoma Test The company said the contract will provide greater access to its DecisionDx-Melanoma gene expression profile test for veterans and active duty military. Personalis Q2 Revenues Rise 11 Percent Revenues from the Veterans Affairs Million Veteran Program shrank slightly while those from non-VA MVP customers were up 74 percent. Personalis Q1 Revenues Grow 9 Percent The firm tallied $20.9 million in revenues compared to $19.2 million a year ago, edging analysts' consensus estimate of $20.4 million. Renalytix AI Lands US Government Contract for Kidney Disease Test The firm said that the contract covers early-stage kidney disease testing that can be provided by more than 140 US government departments, agencies, and affiliates. Jan 28, 2021 Million Veteran Program GWAS Uncovers Genetic Loci Linked to PTSD Jan 26, 2021 Genomind Receives Medicare Coverage for Pharmacogenetics Test Nov 5, 2020 Personalis Q3 Revenues Up 16 Percent Aug 21, 2020 Single-Cell Analysis Reveals Ulcerative Colitis Tissue, Immune Features Aug 6, 2020 Personalis Q2 Revenues Up 23 Percent May 7, 2020 Personalis Q1 Revenues Up 36 Percent May 7, 2020 Prospective Study Adds Evidence for CellMax Life Liquid Biopsy Utility in CRC Screening Premium Jan 7, 2020 Anxiety GWAS On Million Veteran Program Data Uncovers New Loci Nov 13, 2019 Personalis Q3 Revenues Up 47 Percent Oct 9, 2019 PTSD GWAS Meta-Analysis Leads to Identification of Ancestry, Sex-Specific Risk Loci Aug 29, 2019 Veterans Health Administration Precision Oncology Program Successfully Profiles Advanced Tumors Premium Jul 29, 2019 Post-Traumatic Stress Disorder GWAS in Million Veteran Program Participants Identifies Risk Loci Jul 11, 2019 APOLLO Project Launching Prospective Proteogenomic Trial, Expanding Cancer Analyses Premium Mar 12, 2019 First Veterans Affairs MDx Lab Launches NGS-Based Cancer Panel; Others to Follow Premium Mar 12, 2019 VA, Sanford Health to Offer Free PGx Testing to 250K Vets Feb 5, 2019 Foundation Medicine Gets $111.5M Genomic Profiling Contract From VA Department Jan 25, 2019 VA Capacity for Genomics Research Grows as Million Veteran Program Nears 750,000 Enrollees Premium Oct 12, 2018 Researchers Uncover Three New Biomarkers of Active Tuberculosis Oct 1, 2018 Blood Lipid GWAS, PheWAS Leads to Drug Target Gene Sep 19, 2018 Pregnancy Microbiomes Vary With Time, Body Site, Disease Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.